It looks like nothing was found at this location. Maybe try a search?
It looks like nothing was found at this location. Maybe try a search?
March 18, 2024
With a fervent commitment to developing and commercializing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system, clinical-stage biopharmaceutical company CNS Pharmaceuticals (NASDAQ: CNSP) continues to advance its lead drug candidate, Berubicin, along the pathway to potential regulatory approval and commercialization. To boost […]
Rotate your device 90° to view site.